Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.
about
Viral hepatitis and hepatocellular carcinomaHVPG signature: A prognostic and predictive tool in hepatocellular carcinomaImaging of HCC-Current State of the ArtClinical utility of imaging for evaluation of hepatocellular carcinomaCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinomaThe natural history of hepatitis C virus (HCV) infection.Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infectionSofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Percutaneous ablation for small hepatocellular carcinoma.Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.Progression of liver cirrhosis to HCC: an application of hidden Markov model.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis.Is chronic hepatitis C virus infection a risk factor for breast cancer?HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.Laser ablation for small hepatocellular carcinoma.Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirinHepatocellular carcinoma and hepatitis C in the United States.Complications of HIV disease and antiretroviral treatment.Potential treatment options and future research to increase hepatitis C virus treatment response rateHepatocellular carcinoma in patients with autoimmune hepatitis.Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.Hepatitis C virus virology and new treatment targets.Noninvasive monitoring of patients with chronic hepatitis C.Interferon therapy reduces the risk for hepatocellular carcinoma.Labour productivity losses caused by premature death associated with hepatitis C in Spain.The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US.Management of chronic hepatitis C virus infection: a new era of disease control.Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort studyClinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patientsAccuracy of routine clinical ultrasound for staging of liver fibrosis.Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.
P2860
Q21245597-D4A8A895-3B0D-482A-B021-4851AB64B06EQ26738597-C6DBB5CF-EE34-4722-8E6F-2EF629833044Q26768463-41CCF69E-0342-4AB6-BC8B-6F503348BFA0Q26823224-65CD6AC7-A9D0-480C-B096-DC3BE2A15243Q26824893-37BA1180-BE75-4453-9B90-6E477D5B32EAQ27014969-61DD091B-5446-4C1F-B657-1E5C77B15DC3Q27473116-44B8D511-0A87-4BB2-BE07-AED6E69225CFQ28075544-94E7D306-B706-4975-B2F9-2957245A5B80Q30235430-2CBCABF4-FB84-4172-9834-ACFC06162D2FQ30422199-31BF461D-444C-4B25-9F08-0112A859E026Q33427579-CEA2D484-83C6-4A2C-9614-BCA7B2249374Q33516543-5A8FEEA9-D50B-4606-8D65-B61B93305C75Q33594968-391A8F83-864B-449C-97B7-4A45AFED12A3Q33765497-10F287DB-B554-464A-AD39-A181C720C8A9Q33860546-6C0D63CA-2B8E-4180-9C28-3C253DA39E21Q33866448-7C2E1CD3-822C-4208-B4CF-97488AF89343Q33883666-42E719C7-8633-4A8B-BAAE-54649D6714D4Q34041411-2896896A-6832-4821-8D35-94C60A1A202CQ34056283-24664716-810F-44DA-83E4-D5098756C89CQ34108430-C094D754-4D2F-462B-9E56-68B905837682Q34233163-2AEE1774-2ADB-4181-AE11-29C93C135D56Q34528514-6CC3EF2B-BAE5-40FC-BD20-80E662F8B889Q34547655-88D17376-9C72-42BA-9437-65C0D951343DQ34576190-E6A9695B-40D2-4745-919E-9F5CF2EBEA17Q34604173-502B9039-360D-4820-901A-9263D5882CC1Q34770140-9D8837D5-EFF7-449D-AC6B-FE9C3118699DQ34974042-0D9819D8-69A1-4841-AFE4-0C07CB0043CFQ34984046-615FBD1D-CF33-4250-AA3F-67D96E9F8FA0Q35362069-346061B9-444C-492F-843F-5DEDCEF5864EQ35558268-D7F22118-98BE-4D5A-A115-60CE9413D014Q35572125-E3C8C5DE-4351-4CCE-9AB2-4C6BBC6AF7A0Q35590977-DA4718E1-9F1B-41C3-A8EA-7EA74872BB5FQ35621231-4AFC6D45-2343-4C92-8138-314EE7F4853BQ35736293-30E9CEAC-044D-4EEA-8F9A-A794E7BAC1E8Q35823410-A268CED1-F41E-40ED-AFFA-B85842E9EEB3Q36000989-D006DB83-AC4F-4586-BA4A-7CB532C41CA5Q36016030-D81A1DF0-4126-4D6F-AF9F-BDCC11DAC6EAQ36429818-79D149E0-71E7-4EA1-851C-EBD2BA11CE92Q36449657-7F7C86AA-EE91-427C-AE76-CF2F415FF772Q36621548-B6C5BA28-270D-4157-9EFC-BD76903633B3
P2860
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@ast
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@en
type
label
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@ast
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@en
prefLabel
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@ast
Hepatitis C virus related cirr ...... ocellular carcinoma and death.
@en
P2093
P2860
P50
P356
P1433
P1476
Hepatitis C virus related cirr ...... tocellular carcinoma and death
@en
P2093
C Guettier
J C Trinchet
J P Farmachidi
M Beaugrand
P2860
P304
P356
10.1136/GUT.47.1.131
P407
P577
2000-07-01T00:00:00Z